Trump Proposes 100% Tariff on Non-Compliant Drug Makers to Lower Prices
Trump threatens 100% tariff on US drug makers that don’t strike deals to lower prices
The Guardian
Image: The Guardian
Former President Donald Trump has threatened a 100% tariff on pharmaceutical companies that fail to negotiate lower drug prices in the U.S. while exempting generic drugs for one year. The move aims to address high prescription costs that U.S. patients face compared to other developed nations.
- 01100% tariffs proposed on branded drugs not subject to pricing agreements.
- 02Generic drugs, making up over 90% of U.S. medicines, will be exempt for one year.
- 03Large companies have 120 days to negotiate, while smaller firms have 180 days.
- 04Concerns raised about a two-tiered system favoring larger drugmakers.
- 05U.S. patients pay significantly more for prescriptions than those in other developed countries.
Advertisement
In-Article Ad
Donald Trump has announced a potential 100% tariff on pharmaceutical companies that do not negotiate deals to lower drug prices in the United States. This tariff will specifically target branded drugs and their active ingredients, while generic drugs, which constitute over 90% of medicines sold in the U.S., will be exempt for at least one year. Exemptions will also apply to orphan, veterinary, and specialty drugs from trade deal countries or those addressing urgent public health needs. Drugmakers that enter pricing agreements with the White House or increase domestic production will avoid these tariffs. Larger companies have 120 days to negotiate, while smaller companies have 180 days. Critics, including the Midsized Biotech Alliance of America (MBAA), have expressed concerns that the policy could create an “unfair two-tiered system” that benefits larger firms, leaving mid-sized drugmakers vulnerable to sudden cost increases. This announcement comes amid rising pressure on the Biden administration to lower drug prices and address the overall cost of living, which Trump attributes to current economic policies. U.S. patients currently pay nearly three times more for prescription medications compared to those in other developed nations.
Advertisement
In-Article Ad
If implemented, these tariffs could lead to increased drug prices for consumers, particularly affecting those reliant on branded medications.
Advertisement
In-Article Ad
Reader Poll
Do you support implementing tariffs on drug companies to lower prices?
Connecting to poll...
Read the original article
Visit the source for the complete story.

